This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,235.09 firm fixed-price delivery order is for the supply of 4,566,676,103 units of the cardiovascular medication Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of December 11, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order appears to be part of that broader IDC, enabling efficient government procurement of essential medications for military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating open competition.
Generated 3/11/25, 9:58 AM